國立虎尾科技大學 |

登入

回首頁

Guide to Targeted Therapies: Treatme...

SpringerLink (Online service)

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Guide to Targeted Therapies: Treatment Resistance in Lung Cancer/ by Federico Cappuzzo.
作者:	Cappuzzo, Federico.
面頁冊數:	VII, 67 p. 14 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-20741-4
ISBN:	9783319207414

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer
Cappuzzo, Federico.

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer[electronic resource] /by Federico Cappuzzo. - 1st ed. 2015. - VII, 67 p. 14 illus. in color.online resource.

Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options.- Conclusions.

This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.

ISBN: 9783319207414

Standard No.: 10.1007/978-3-319-20741-4doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Guide to Targeted Therapies: Treatment Resistance in Lung Cancer
LDR:01933nam a22003855i 4500 001 962237
003 DE-He213
005 20200704123045.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319207414 $9 978-3-319-20741-4
024 7 $a 10.1007/978-3-319-20741-4 $2 doi
035 $a 978-3-319-20741-4
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
100 1 $a Cappuzzo, Federico. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1070067
245 1 0 $a Guide to Targeted Therapies: Treatment Resistance in Lung Cancer $h [electronic resource] / $c by Federico Cappuzzo.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2015.
300 $a VII, 67 p. 14 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options.- Conclusions.
520 $a This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
650 0 $a Oncology . $3 1253469
650 1 4 $a Oncology. $3 593951
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319207407
776 0 8 $i Printed edition: $z 9783319207421
856 4 0 $u https://doi.org/10.1007/978-3-319-20741-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得

Export

取書館別